Cardiovascular diseases in end-stage renal disease patients with peritoneal dialysis
10.3760/cma.j.issn.1001-7097.2009.01.005
- VernacularTitle:终末期肾脏病腹膜透析患者的心血管疾病
- Author:
Shan MOU
;
Beili SHI
;
Qin WANG
;
Liou CAO
;
Wenyan ZHOU
;
Meihua YU
;
Zhaohui NI
;
Jiaqi QIAN
- Publication Type:Journal Article
- Keywords:
Uremia;
Peritoneal dialysis;
Cardiovascular diseases
- From:
Chinese Journal of Nephrology
2009;25(1):18-23
- CountryChina
- Language:Chinese
-
Abstract:
Objective To elucidate the prevalence and risk factors of cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients on peritoneal dialysis (PD), and to investigate the associated problems in treatment. Methods A total of 254 PD patients in our division were enrolled in this study. CVD history, laboratory measurements, examinations of carotid atherosclerosis and left ventricular hypertrophy by ultrasonography were collected and associated factors were analyzed. The median follow-up time was 49 months. Results The overall prevalence of CVD was 37% (93/254). Diabetes, longer dialysis duration, hypertfiglyceridemia, hypoalbuminemia, hypoprealbuminemia were commonly found in the patients with new CVD event. The patients without pre-existing CVD had the higher Ccr, Kt/V, D/Pr, nPCR, serum albumin level. In those with pre-existing CVD, the hypertriglyceridemia and the duration of dialysis were independent predictors of progression of CVD. Differences of LAD, LVST, LVMI and IMT were significant between with and without pre-existing CVD groups. Kaplan-Meier curves showed that the presence of CVD was the independent risk factor of survival. Alb<330 g/L, LAD>39.6 mm and peritonitis were risk factors of CVD. Conclusion The prevalence of CVD in PD patients is quite high. CVD history should be realized, dialysis adequacy should be maintained, and peritonitis should be prevented.
